| |
Screening
|
Immediate phase (intravenous drip of salvianolate for 30 min)
|
In-hospital follow-up
|
|---|
|
Day 1
|
Day 1
|
Day 7
|
|---|
|
Inclusion/exclusion criteria
|
X
| | |
|
Informed consent
|
X
| | |
|
Randomization
|
X
| | |
|
Demographic information
|
X
| | |
|
Medical history
|
X
| | |
|
Vital signs
|
X
|
X
|
X
|
|
Physical examination
|
X
| |
X
|
|
Concomitant medications
|
X
| |
X
|
|
CBC
|
X
| |
X
|
|
Scr, BUN, UA
|
X
| |
X
|
|
K, Na, Cl
|
X
| |
X
|
|
ALT, AST, BIL
|
X
| |
X
|
|
Fasting glucose/lipids
|
X
| |
X
|
|
cTnT/cTnI
|
X
| |
X
|
|
Electrocardiography
|
X
| |
X
|
|
Echocardiography
|
X
| |
X
|
|
Medication
|
|
Salvianolate injection
| |
X
|
X
|
|
End points
|
|
Seattle angina scale
|
X
| |
X
|
|
Quality of life scale
|
X
| |
X
|
|
Holter electrocardiography
|
X
| |
X
|
|
6-min walk test
|
X
| |
X
|
|
IMR
|
X
|
X
| |
- CBC, complete blood count; Scr, serum creatinine; BUN, blood urea nitrogen; UA, uric acid; K, potassium; Na, sodium; Cl, chloride; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BIL, bilirubin; cTnT/cTnI, cardiac troponin T/I; IMR, index of microcirculatory resistance
